Caffeic acid phenethyl ester modulates Helicobacter pylori-induced nuclear factor-kappa B and activator protein-1 expression in gastric epithelial cells

Br J Pharmacol. 2005 Dec;146(8):1139-47. doi: 10.1038/sj.bjp.0706421.

Abstract

Caffeic acid phenethyl ester (CAPE), an active component of propolis from honeybee hives (honeybee resin), has anti-inflammatory, anti-carcinogenic and anti-bacterial properties. This study was designed to investigate the anti-inflammatory effects of CAPE on Helicobacter pylori-induced NF-kappaB and AP-1 in the gastric epithelial cell line AGS. Electrophoretic mobility shift assay was used to measure NF-kappaB- and AP-1-DNA binding activity. Western blotting was used to detect IkappaB-alpha and COX-2 expression in AGS cells cocultured with H. pylori. The antiproliferative effect of CAPE was measured by MTT assay. Our results showed that caffeic phenethyl ester inhibits H. pylori-induced NF-kappaB and AP-1 DNA-binding activity in a dose (0.1-25 microg ml(-1) approximately 0.35-88 microM) and time- (15-240 min) dependent manner in AGS cells. Maximum inhibition by CAPE was observed at concentrations of 25 microg ml(-1) ( approximately 88 microM) CAPE prevented H. pylori- and cytokine-induced degradation of IkappaB-alpha protein. Pretreatment of AGS cells with CAPE also blocked cytokine- and mitogen-induced NF-kappaB and AP-1 expression. Furthermore, CAPE suppressed H. pylori-induced cell proliferation and production of the cytokines TNF-alpha and IL-8. In addition, CAPE blocked H. pylori-induced COX-2 expression. The inhibition of such transcription by CAPE could result in suppression of many genes during H. pylori-induced inflammation, and also provide new insights into the anti-cancer and anti-inflammatory properties of CAPE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus / drug effects
  • Anti-Inflammatory Agents / pharmacology*
  • Caffeic Acids / pharmacology*
  • Cell Line, Tumor
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism*
  • Cell Nucleus / microbiology
  • Cell Proliferation / drug effects
  • Cyclooxygenase 2 / metabolism
  • Cytokines / metabolism
  • DNA / metabolism
  • Dose-Response Relationship, Drug
  • Epithelial Cells / drug effects*
  • Epithelial Cells / enzymology
  • Epithelial Cells / microbiology
  • Gastric Mucosa / drug effects*
  • Gastric Mucosa / enzymology
  • Gastric Mucosa / microbiology
  • Helicobacter Infections / metabolism*
  • Helicobacter Infections / prevention & control
  • Helicobacter pylori*
  • Humans
  • I-kappa B Proteins / metabolism
  • Membrane Proteins / metabolism
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / metabolism*
  • Phenylethyl Alcohol / analogs & derivatives*
  • Phenylethyl Alcohol / pharmacology
  • Time Factors
  • Transcription Factor AP-1 / metabolism*
  • Transcription Factor RelA / metabolism*
  • Transcription, Genetic / drug effects

Substances

  • Anti-Inflammatory Agents
  • Caffeic Acids
  • Cytokines
  • I-kappa B Proteins
  • Membrane Proteins
  • NF-kappa B
  • NFKBIA protein, human
  • Transcription Factor AP-1
  • Transcription Factor RelA
  • NF-KappaB Inhibitor alpha
  • DNA
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • caffeic acid phenethyl ester
  • Phenylethyl Alcohol